High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
D000293:Adolescent; D000328:Adult; D003401:Creatine / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D004231:Diuresis; D005260:Female; D005665:Furosemide / Q000008:administration & dosage* / Q000633:toxicity; D006073:Gout; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007008:Hypokalemia / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008657:Metabolic Clearance Rate; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D011188:Potassium / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy; D012964:Sodium / Q000097:blood / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014556:Urine / Q000502:physiology
D014527:Uric Acid; D013148:Spironolactone; D008750:Methyldopa; D005665:Furosemide; D014508:Urea; D012964:Sodium; D003404:Creatinine; D003401:Creatine; D011188:Potassium